Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ming C. LIAU"'
Publikováno v:
Cancer Biology & Medicine, Vol 7, Iss 2, Pp 86-96 (2010)
OBJECTIVE The objective was to study the relationship between the tumor factor of cancer MATLT and the catalytic subunit of telomerase. The function of telomerase in the blockade of cell differentiation and in the protection of DNA MT resembles close
Externí odkaz:
https://doaj.org/article/22b4afb41ddd4bce9185bdc34132868e
Autor:
Christine Liau Craig, Ming C. Liau
Publikováno v:
Journal of Cancer and Tumor International. :29-34
Wound healing and cancer evolution are closely related to involve progenitor Stem Cells (PSCs) as the critical common elements. Wound healing requires the proliferation and the Terminal Differentiation (TD) of PSCs. Wound triggers biological and immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86b8fd48f05e3675fcaa04ef4ac1719a
https://doi.org/10.9734/jcti/2022/v12i130168
https://doi.org/10.9734/jcti/2022/v12i130168
Autor:
Ming C Liau, John P Fruehauf
Publikováno v:
International Journal of Research in Oncology. 1
The objective of this study was to develop winning formulas to fulfill cancer moonshot declared by President Biden on Sept. 12, 2022, the 60th anniversary of the moonshot speech of President Kennedy. The intention of President Biden was to use the sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64e4d4756f6cc486487a0c579cb9135e
https://doi.org/10.33425/2833-0390.1007
https://doi.org/10.33425/2833-0390.1007
Autor:
Ming C Liau, Linda Liau Baker
Publikováno v:
Cancer Science & Research. 5
Solution of cancer was obviously an important national interest for President Nixon to declare ‘War on Cancer” in 1971. Health professionals failed the challenge to put cancer away during the 5 years of intensive presidential support and in the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cd3bda58e9c28ca3d4e0449df19600c
https://doi.org/10.33425/2639-8478.1089
https://doi.org/10.33425/2639-8478.1089
Publikováno v:
Journal of Cancer and Tumor International. :39-47
Cell differentiation agent-2 (CDA-2) was a promising hypomethylating agent approved by the Chinese FDA for the therapy of MDS in China. The active components of CDA-2 are differentiation inducers (DIs) and differentiation helper inducers (DHIs). DIs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03d2477865188e714a12eb8c02273d4a
https://doi.org/10.9734/jcti/2020/v10i230125
https://doi.org/10.9734/jcti/2020/v10i230125
Autor:
Linda Liau Baker, Ming C Liau
This review highlights the impact of wound onto the evolution and therapy of cancer. The objective of this review is to explore the mechanism of wound healing and its relationship to the evolution and therapy of cancer. Wound healing requires the pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1f583aaec89dce53d5974d3a0a6d794
https://doi.org/10.9734/bpi/rdmmr/v8/2652e
https://doi.org/10.9734/bpi/rdmmr/v8/2652e
The objective of this study was to develop cancer drugs effective to take out both cancer stem cells (CSCs) and cancer cells, particularly CSCs since these cells stood in the way to deny the success of conventional therapies to put cancer away. The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::031759a3365a47b97278bc254ea00451
https://doi.org/10.9734/bpi/caprd/v2/13544d
https://doi.org/10.9734/bpi/caprd/v2/13544d
All Trans Retinoic Acid (ATRA) is a Differentiation Inducer (DI) of Acute Promyelocytic Leukemia (APL) with proven clinical utility. Its benefits for other types of Acute Myelocytic Leukemia (AML) have been limited. In APL, ATRA targets the PML-RARA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e210836a816aa25e249a2940cbc7bfbe
https://doi.org/10.9734/bpi/nfmmr/v11/3824f
https://doi.org/10.9734/bpi/nfmmr/v11/3824f